Microbiology FDA 483 (Jiangsu Hengrui Pharmceuticals): Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic and sterilization process
Product contact equipment including *** stopper drums, *** were sterilized without outer wrapping and transferred from Grade A cart to